|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Orditura M, Galizia G, Sforza V, et al:
Treatment of gastric cancer. World J Gastroenterol. 20:1635–1649.
2014. View Article : Google Scholar
|
|
3
|
Yasui W, Oue N, Aung PP, Matsumura S,
Shutoh M and Nakayama H: Molecular-pathological prognostic factors
of gastric cancer: a review. Gastric Cancer. 8:86–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Correa P: Human gastric carcinogenesis: a
multistep and multifactorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52:6735–6740. 1992.
|
|
5
|
Uemura N, Okamoto S, Yamamoto S, et al:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar
|
|
6
|
Houghton J, Stoicov C, Nomura S, et al:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hiyama E, Yokoyama T, Tatsumoto N, et al:
Telomerase activity in gastric cancer. Cancer Res. 55:3258–3262.
1995.PubMed/NCBI
|
|
8
|
Zheng L, Wang L, Ajani J and Xie K:
Molecular basis of gastric cancer development and progression.
Gastric Cancer. 7:61–77. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tahara E: Genetic pathways of two types of
gastric cancer. IARC Sci Publ. 157:327–349. 2004.PubMed/NCBI
|
|
10
|
Aitken A: 14-3-3 proteins: a historic
overview. Semin Cancer Biol. 16:162–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mackintosh C: Dynamic interactions between
14-3-3 proteins and phosphoproteins regulate diverse cellular
processes. Biochem J. 381:329–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi W, Liu X, Qiao D and Martinez JD:
Isoform-specific expression of 14-3-3 proteins in human lung cancer
tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li DQ, Wang L, Fei F, et al:
Identification of breast cancer metastasis-associated proteins in
an isogenic tumor metastasis model using two-dimensional gel
electrophoresis and liquid chromatography-ion trap-mass
spectrometry. Proteomics. 6:3352–3368. 2006. View Article : Google Scholar
|
|
14
|
Wang Z, Nesland JM, Suo Z, Trope CG and
Holm R: The prognostic value of 14-3-3 isoforms in vulvar squamous
cell carcinoma cases: 14-3-3beta and epsilon are independent
prognostic factors for these tumors. PLoS One. 6:e248432011.
View Article : Google Scholar
|
|
15
|
Sofiadis A, Becker S, Hellman U, et al:
Proteomic profiling of follicular and papillary thyroid tumors. Eur
J Endocrinol. 166:657–667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Tian RF, Li YM, et al: The
expression of seven 14-3-3 isoforms in human meningioma. Brain Res.
1336:98–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ko BS, Chang TC, Hsu C, et al:
Overexpression of 14-3-3epsilon predicts tumour metastasis and poor
survival in hepatocellular carcinoma. Histopathology. 58:705–711.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gradilone SA, Radtke BN, Bogert PS, Huang
BQ, Gajdos GB and LaRusso NF: HDAC6 inhibition restores ciliary
expression and decreases tumor growth. Cancer Res. 73:2259–2270.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vázquez-Vega S, Contreras-Paredes A,
Lizano-Soberón M, Amador-Molina A, García-Carrancá A,
Sánchez-Suárez LP and Benítez-Bribiesca L: RNA interference (RNAi)
and its therapeutic potential in cancer. Rev Invest Clin. 62:81–90.
2010.(In Spanish).
|
|
20
|
Sen GL and Blau HM: A brief history of
RNAi: the silence of the genes. FASEB J. 20:1293–1299. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qian J, Liu H, Chen W, Wen K, Lu W, Huang
C and Fu Z: Knockdown of Slug by RNAi inhibits the proliferation
and invasion of HCT116 colorectal cancer cells. Mol Med Rep.
8:1055–1059. 2013.PubMed/NCBI
|
|
22
|
Yan L, Gu H, Li J, et al: RKIP and
14-3-3epsilon exert an opposite effect on human gastric cancer
cells SGC7901 by regulating the ERK/MAPK pathway differently. Dig
Dis Sci. 58:389–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kawauchi S, Yamamoto Y, Uchida K, Chochi
Y, Kondo T, Oga A and Sasaki K: Significance of cyclin E and p27
expression in malignant ovarian germ cell tumors: correlation with
the cell proliferation activity and clinicopathologic features.
Oncol Rep. 16:1029–1033. 2006.PubMed/NCBI
|
|
24
|
Che XH, Chen H, Xu ZM, Shang C, Sun KL and
Fu WN: 14-3-3epsilon contributes to tumour suppression in laryngeal
carcinoma by affecting apoptosis and invasion. BMC Cancer.
10:3062010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kosaka Y, Cieslik KA, Li L, et al:
14-3-3epsilon plays a role in cardiac ventricular compaction by
regulating the cardiomyocyte cell cycle. Mol Cell Biol.
32:5089–5102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazumder S, Plesca D and Almasan A: A
jekyll and hyde role of cyclin E in the genotoxic stress response:
switching from cell cycle control to apoptosis regulation. Cell
Cycle. 6:1437–1442. 2007. View Article : Google Scholar
|
|
27
|
Mitrea DM, Yoon MK, Ou L and Kriwacki RW:
Disorder-function relationships for the cell cycle regulatory
proteins p21 and p27. Biol Chem. 393:259–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Milton AH, Khaire N, Ingram L, O’Donnell
AJ and La Thangue NB: 14-3-3 proteins integrate E2F activity with
the DNA damage response. EMBO J. 25:1046–1057. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mackintosh C: Dynamic interactions between
14-3-3 proteins and phosphoproteins regulate diverse cellular
processes. Biochem J. 381:329–342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujita N, Sato S, Katayama K and Tsuruo T:
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3
and cytoplasmic localization. J Biol Chem. 277:28706–28713. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujita N, Sato S and Tsuruo T:
Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal
protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic
localization. J Biol Chem. 278:49254–49260. 2003. View Article : Google Scholar
|
|
32
|
Wang W, Ungermannova D, Jin J, Harper JW
and Liu X: Negative regulation of SCFSkp2 ubiquitin ligase by
TGF-beta signaling. Oncogene. 23:1064–1075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leal M, Calcagno D, Demachki S, Assumpção
P, Chammas R, Burbano R and Smith M: Clinical implication of 14-3-3
epsilon expression in gastric cancer. World J Gastroenterol.
18:1531–1537. 2012. View Article : Google Scholar : PubMed/NCBI
|
